Michael Gilbertson

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

Tarec Christoffer El‐Galaly, Chan Y. Cheah, Mette Dahl Bendtsen et al. · European Journal of Cancer · 2018 · 130 citations · Full text

Prognostic Factors, Neuro-oncology, Lymphoid Neoplasia +7

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

Chan Y. Cheah, Kirsten Herbert, Kacey O’Rourke et al. · British Journal of Cancer · 2014 · 129 citations · Full text

The BTK Inhibitor, Bgb-3111, Is Safe, Tolerable, and Highly Active in Patients with Relapsed/ Refractory B-Cell Malignancies: Initial Report of a Phase 1 First-in-Human Trial

Constantine S. Tam, Andrew Grigg, Stephen Opat et al. · Blood · 2015 · 111 citations

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

Claire Dendle, Michael Gilbertson, Tim Spelman et al. · Scientific Reports · 2017 · 33 citations · Full text

Disseminated Enteroviral Infection Associated with Obinutuzumab

Claire Dendle, Michael Gilbertson, Tony M. Korman et al. · Emerging infectious diseases · 2015 · 26 citations · Full text

Autoimmune Disease, Intravenous Immunoglobulin, Pathogenesis +14